Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis

被引:10
作者
He, Wei [1 ]
Zhao, Caifang [1 ]
Hu, Huixian [1 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Hematol, Sch Med, Jinhua, Zhejiang, Peoples R China
关键词
RUNX1; mutations; myelodysplastic syndromes; prognosis; meta-analysis;
D O I
10.1080/16078454.2020.1858598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives RUNX1 mutations have been widely found in patients with myelodysplastic syndrome (MDS). Majority of reports revealed that RUNX1 mutations are associated with a poor prognosis. However, discrepancies still remain. The results of univariate analysis were not confirmed in multivariate analysis in some cases. Therefore, we performed a meta-analysis to assess the prognostic effect of RUNX1 mutations in MDS. Methods We extracted data from qualified studies that were searched from PubMed, Embase and the Cochrane Library. Hazard ratios (HRs) and their 95% confidence intervals (CIs) for the overall survival (OS) and leukemia free survival (LFS) were pooled from the multivariate Cox proportional hazard models. Results Sixteen studies containing 5422 patients were included in this meta-analysis. There were 617 patients with mutated RUNX1 and 4805 patients with wide type RUNX1. The total HR for OS was 1.43 (95% CI = 1.21-1.70, P < 0.0001) and the counterpart of LFS was 1.88 (95% CI = 1.42-2.51, P < 0.0001). Discussion and conclusion These results suggest that the RUNX1 mutations are associated with unfavorable outcomes and shorter survival in patients with MDS. Furthermore, poor prognosis of patients might be alleviated by stem cell transplantation. Patients bearing these mutations should be prioritized for aggressive therapy.
引用
收藏
页码:494 / 501
页数:8
相关论文
共 50 条
[41]   Transcriptional Regulation of RUNX1: An Informatics Analysis [J].
Thomas, Amarni L. ;
Marsman, Judith ;
Antony, Jisha ;
Schierding, William ;
O'Sullivan, Justin M. ;
Horsfield, Julia A. .
GENES, 2021, 12 (08)
[42]   IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes [J].
Wang, Na ;
Wang, Fei ;
Shan, Ningning ;
Sui, Xiaohui ;
Xu, Hongzhi .
ACTA HAEMATOLOGICA, 2017, 138 (03) :143-151
[43]   Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma [J].
Feng, Xiaodong ;
Zheng, Zhiwei ;
Wang, Yi ;
Song, Guanghui ;
Wang, Lu ;
Zhang, Zhijun ;
Zhao, Jinxia ;
Wang, Qing ;
Lun, Limin .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (05) :538-546
[44]   Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis [J].
Wan, Ziqi ;
Han, Bing .
FRONTIERS IN ONCOLOGY, 2020, 10
[45]   Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis [J].
Victor Moyo ;
Patrick Lefebvre ;
Mei Sheng Duh ;
Behin Yektashenas ;
Suneel Mundle .
Annals of Hematology, 2008, 87 :527-536
[46]   Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis [J].
Moyo, Victor ;
Lefebvre, Patrick ;
Duh, Mei Sheng ;
Yektashenas, Behin ;
Mundle, Suneel .
ANNALS OF HEMATOLOGY, 2008, 87 (07) :527-536
[47]   Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis [J].
Sheikhi, Maryam ;
Rostami, Mehrdad ;
Ferns, Gordon ;
Ayatollahi, Hossein ;
Siyadat, Payam ;
Ayatollahi, Yasamin ;
Khoshnegah, Zahra .
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2024, 15 (02) :202-214
[48]   PHF6 and RUNX1 mutations cooperate to accelerate leukemogenesis [J].
Hsu, Yueh-Chwen ;
Yao, Chi-Yuan ;
Yuan, Chang-Tsu ;
Lin, Chien-Chin ;
Hou, Hsin-An ;
Kao, Chein-Jun ;
Hsu, Chia-Lang ;
Chou, Wen-Chien ;
Tien, Hwei-Fang .
TRANSLATIONAL ONCOLOGY, 2025, 59
[49]   Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes [J].
Liu, Liu ;
Jia, Menglu ;
Sun, Ling ;
Tian, Wenliang ;
Tang, Ping ;
Jiang, Zhongxing .
CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (04) :537-543
[50]   Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes [J].
Liu Liu ;
Menglu Jia ;
Ling Sun ;
Wenliang Tian ;
Ping Tang ;
Zhongxing Jiang .
Clinical and Experimental Medicine, 2021, 21 :537-543